Loading...
Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies
The development of new diagnostic assays become a priority for managing COVID-19. To this aim, we presented here an in-house ELISA based on the production of two major recombinant and high-quality antigens from SARS-CoV-2. Full-length N and S-RBD fragment proteins fused to mouse IgG2a-Fc were produc...
Na minha lista:
| Udgivet i: | J Immunol Methods |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier B.V.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8152238/ https://ncbi.nlm.nih.gov/pubmed/34051226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2021.113082 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|